nelarabine
NDC 81927-111, nelarabine, injection, from Shorla Oncology Inc..
- Product NDC
- 81927-111
- Status
- Listed
- Labeler
- Shorla Oncology Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214809
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81927-111 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NELARABINE5 mg/mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81927-111-01 | 81927011101 | 1 VIAL, SINGLE-DOSE in 1 CARTON (81927-111-01) / 50 mL in 1 VIAL, SINGLE-DOSE |
| 81927-111-06 | 81927011106 | 6 VIAL, SINGLE-DOSE in 1 CARTON (81927-111-06) / 50 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fc401b06-4e3b-413e-a854-3e031c433862Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=81927-111
Use it
Look up 81927-111 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81927-111 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81927-111. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.